Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus

Daniel A. Grabell, Loderick A. Matthews, Kim B. Yancey, Benjamin F. Chong

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

IMPORTANCE: Anti-type VII collagen autoantibodies are often detectable in patients with bullous systemic lupus erythematosus (BSLE). However, the timing of their appearance preceding the onset of disease is unknown to date. OBSERVATIONS: We report the case of a 50-year-old woman with a history of SLE who was seen with vesicles and bullae around her lips, trunk, axillae, arms, and thighs. Histologic analysis and immunofluorescence and immunoblot studies confirmed the diagnosis of BSLE. Immunoblottingand enzyme-linked immunosorbent assay studies of the patient's serum obtained 3 months before the onset of BSLE showed the presence of anti-type VII collagen autoantibodies. Levels of anti-type VII collagen IgG increased after bullous lesions appeared. Within 1 month after initiating dapsone therapy and increasing the dosage of prednisone, skin lesions promptly resolved. One year after the onset of BSLE, the anti-type VII collagen IgG decreased below levels observed before the inception of the bullous lesions. CONCLUSIONS AND RELEVANCE: Anti-type VII collagen autoantibodies can precede the clinical appearance of BSLE. The subsequent increase and decrease in levels of circulating anti-type VII collagen autoantibodies, which mirrored skin disease activity, support a potential role in their initiation of disease.

Original languageEnglish (US)
Pages (from-to)539-543
Number of pages5
JournalJAMA Dermatology
Volume151
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Collagen Type VII
Systemic Lupus Erythematosus
Autoantibodies
Blister
Immunoglobulin G
Dapsone
Axilla
Lip
Prednisone
Thigh
Skin Diseases
Fluorescent Antibody Technique
Arm
Enzyme-Linked Immunosorbent Assay
Skin
Serum

ASJC Scopus subject areas

  • Dermatology

Cite this

Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus. / Grabell, Daniel A.; Matthews, Loderick A.; Yancey, Kim B.; Chong, Benjamin F.

In: JAMA Dermatology, Vol. 151, No. 5, 01.05.2015, p. 539-543.

Research output: Contribution to journalArticle

@article{d5db3db4b6fe4407b24fa29e42f4c2a3,
title = "Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus",
abstract = "IMPORTANCE: Anti-type VII collagen autoantibodies are often detectable in patients with bullous systemic lupus erythematosus (BSLE). However, the timing of their appearance preceding the onset of disease is unknown to date. OBSERVATIONS: We report the case of a 50-year-old woman with a history of SLE who was seen with vesicles and bullae around her lips, trunk, axillae, arms, and thighs. Histologic analysis and immunofluorescence and immunoblot studies confirmed the diagnosis of BSLE. Immunoblottingand enzyme-linked immunosorbent assay studies of the patient's serum obtained 3 months before the onset of BSLE showed the presence of anti-type VII collagen autoantibodies. Levels of anti-type VII collagen IgG increased after bullous lesions appeared. Within 1 month after initiating dapsone therapy and increasing the dosage of prednisone, skin lesions promptly resolved. One year after the onset of BSLE, the anti-type VII collagen IgG decreased below levels observed before the inception of the bullous lesions. CONCLUSIONS AND RELEVANCE: Anti-type VII collagen autoantibodies can precede the clinical appearance of BSLE. The subsequent increase and decrease in levels of circulating anti-type VII collagen autoantibodies, which mirrored skin disease activity, support a potential role in their initiation of disease.",
author = "Grabell, {Daniel A.} and Matthews, {Loderick A.} and Yancey, {Kim B.} and Chong, {Benjamin F.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1001/jamadermatol.2014.4409",
language = "English (US)",
volume = "151",
pages = "539--543",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Detection of type VII collagen autoantibodies before the onset of bullous systemic lupus erythematosus

AU - Grabell, Daniel A.

AU - Matthews, Loderick A.

AU - Yancey, Kim B.

AU - Chong, Benjamin F.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - IMPORTANCE: Anti-type VII collagen autoantibodies are often detectable in patients with bullous systemic lupus erythematosus (BSLE). However, the timing of their appearance preceding the onset of disease is unknown to date. OBSERVATIONS: We report the case of a 50-year-old woman with a history of SLE who was seen with vesicles and bullae around her lips, trunk, axillae, arms, and thighs. Histologic analysis and immunofluorescence and immunoblot studies confirmed the diagnosis of BSLE. Immunoblottingand enzyme-linked immunosorbent assay studies of the patient's serum obtained 3 months before the onset of BSLE showed the presence of anti-type VII collagen autoantibodies. Levels of anti-type VII collagen IgG increased after bullous lesions appeared. Within 1 month after initiating dapsone therapy and increasing the dosage of prednisone, skin lesions promptly resolved. One year after the onset of BSLE, the anti-type VII collagen IgG decreased below levels observed before the inception of the bullous lesions. CONCLUSIONS AND RELEVANCE: Anti-type VII collagen autoantibodies can precede the clinical appearance of BSLE. The subsequent increase and decrease in levels of circulating anti-type VII collagen autoantibodies, which mirrored skin disease activity, support a potential role in their initiation of disease.

AB - IMPORTANCE: Anti-type VII collagen autoantibodies are often detectable in patients with bullous systemic lupus erythematosus (BSLE). However, the timing of their appearance preceding the onset of disease is unknown to date. OBSERVATIONS: We report the case of a 50-year-old woman with a history of SLE who was seen with vesicles and bullae around her lips, trunk, axillae, arms, and thighs. Histologic analysis and immunofluorescence and immunoblot studies confirmed the diagnosis of BSLE. Immunoblottingand enzyme-linked immunosorbent assay studies of the patient's serum obtained 3 months before the onset of BSLE showed the presence of anti-type VII collagen autoantibodies. Levels of anti-type VII collagen IgG increased after bullous lesions appeared. Within 1 month after initiating dapsone therapy and increasing the dosage of prednisone, skin lesions promptly resolved. One year after the onset of BSLE, the anti-type VII collagen IgG decreased below levels observed before the inception of the bullous lesions. CONCLUSIONS AND RELEVANCE: Anti-type VII collagen autoantibodies can precede the clinical appearance of BSLE. The subsequent increase and decrease in levels of circulating anti-type VII collagen autoantibodies, which mirrored skin disease activity, support a potential role in their initiation of disease.

UR - http://www.scopus.com/inward/record.url?scp=84929665621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929665621&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2014.4409

DO - 10.1001/jamadermatol.2014.4409

M3 - Article

C2 - 25671758

AN - SCOPUS:84929665621

VL - 151

SP - 539

EP - 543

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 5

ER -